Tirzepatide's Zepbound label reports similar figures, with nausea at 31% and constipation at 17% at the 15 mg dose in SURMOUNT-1 [2][4]
When you begin GLP-1 therapy, youre essentially enhancing a hormone your body already uses to regulate appetite and blood sugar
This difference can influence a patients preference based on convenience and comfort with needles versus pills
The PlexusDx Precision Peptide Genetic Test analyzes key variants in the GLP1R gene (such as rs6923761), the MC4R gene (rs17782313), and the FTO obesity-risk gene (rs9939609) to map your personalized peptide pathway profile across 14 appetite, metabolic, and reward pathways
Overall, Tirzepatide offers a new approach to managing type 2 diabetes, and its potential benefits may outweigh the risks for some individuals
This is a predictable result but one that carries a simple and important message remember to take your B12